Mercury Didn't Sell. That Means Something.
Profitability isn't a smaller version of growth. It's a different kind of leverage.
Earlier this year, Capital One bought Brex. Peak valuation $12.3 billion. Sale price $5.15 billion. About half.
The lesson wasn't that anyone screwed up. It was that growth has a price tag, and sooner or later someone comes to collect.
Then, a couple weeks ago, the other shoe didn't drop.
Mercury — another startup-favorite bank, same investor list, same generation — raised $200 million at a $5.2 billion valuation. Up 49% in fourteen months. $650 million in annualized revenue. Four straight years of profitability on a GAAP basis. One in three U.S. startups now banks with them.
And the CEO, Immad Akhund, told Inc.: "We've been profitable for four years, so we don't have a plan to do another raise."
That's not a press release flex. That's a structural choice.
Two banks. Two paths. One lesson.
Brex and Mercury were drafted into the same category. Both bank startups. Both raised from the same names — Andreessen, Sequoia, Coatue. Both had a real shot at being "the future of how founders move money."
Then they took different routes.
Brex chased growth. Mercury chased profitability. Brex priced for an exit. Mercury didn't price for one at all. One sold at half its peak. The other just got handed a bigger number than ever and (politely) said no thanks.
You don't have to think one of them was "right." Both companies still exist. Both still have customers. Brex didn't fail — it transitioned. Mercury didn't win — it just bought itself another decade of being the company it wants to be.
But if you're a bootstrapped founder watching this from the cheap seats, the contrast is the lesson:
Profitability isn't a smaller version of growth. It's a different kind of leverage.
The thing Mercury actually bought
The headline was the $5.2 billion. The interesting part was what Akhund said next — that there's no plan to raise again. That sentence is the product of four years of compounding margin, not a quarter of cost-cutting.
When you're profitable, you get to do something almost nobody else can: say no. No to a bad acquirer. No to a strategic that wants 60% of the company. No to a round that comes with a board seat and a different definition of "winning." No to selling at half your peak because the music stopped at an inconvenient moment.
That's not a moat. It's something better. It's optionality.
Brex didn't lose. Brex got priced. Mercury didn't win. Mercury bought time.
And time, for a founder, is the only currency that compounds.
What this has to do with you
Most of us aren't running $650M-ARR fintechs. We're running businesses where the difference between "fine" and "we have a problem" is a single late invoice or a vendor renewal nobody flagged.
But the principle scales down cleanly.
A profitable small business gets to wait out a bad month. A profitable nonprofit gets to keep its programs running while a grant gets delayed. A profitable founder doesn't have to take the call they didn't want to take.
The math is the same. The reason most of us don't get there isn't that we can't — it's that we can't see the math clearly enough to act on it in time. By the time the bank balance whispers, the runway has already screamed.
That's the part we keep working on at MyRunwayHealth. Not "how do I make more money," but "how do I see the shape of my own business clearly enough to decide, instead of react."
Final Thoughts
It's not about whether to take money.
It's not about whether to sell.
It's about whether you're the one who gets to decide.
And if you build the kind of business that can survive without anyone else's permission? You don't have to outrun the next downturn, the next vendor squeeze, the next "strategic conversation." You just have to keep doing what already works.
So — what's the one number in your business that, if you knew it cold every week, would let you say no when it mattered?
